Sangamo Therapeutics
SGMO
$3.67
Share price
3.09%
Change (1 day)
-35.50%
Change (1 year)
Categories
Revenue for Sangamo Therapeutics (SGMO)
Revenue in 2022 (TTM): $0.11 B
According to Sangamo Therapeutics 's latest financial reports the company's current revenue (TTM) is $0.11 B. In 2021 the company made a revenue of $0.11 B a decrease over the years 2020 revenue that were of $0.11 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Sangamo Therapeutics from 2001 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 (TTM) | $0.11 B | 1.22% |
| 2021 | $0.11 B | -6.34% |
| 2020 | $0.11 B | 15.39% |
| 2019 | $0.10 B | 21.29% |
| 2018 | $84.45 M | 130.95% |
| 2017 | $36.56 M | 88.6% |
| 2016 | $19.38 M | -50.96% |
| 2015 | $39.53 M | -13.8% |
| 2014 | $45.87 M | 90.07% |
| 2013 | $24.13 M | 11.44% |
| 2012 | $21.65 M | 109.86% |
| 2011 | $10.31 M | -50.4% |
| 2010 | $20.8 M | -6.23% |
| 2009 | $22.18 M | 37.08% |
| 2008 | $16.18 M | 77.91% |
| 2007 | $9.09 M | 15.38% |
| 2006 | $7.88 M | 217.56% |
| 2005 | $2.48 M | 88.82% |
| 2004 | $1.31 M | -49.01% |
| 2003 | $2.57 M | -40.62% |
| 2002 | $4.34 M | -11.1% |
| 2001 | $4.88 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $96.04 B | 85,608.80% | 🇺🇸 USA |
 Amgen AMGN | $26.33 B | 23,397.39% | 🇺🇸 USA |
 Biogen BIIB | $10.36 B | 9,148.32% | 🇺🇸 USA |
 Dow DOW | $59.40 B | 52,915.93% | 🇺🇸 USA |
 Gilead Sciences GILD | $27.13 B | 24,116.68% | 🇺🇸 USA |
 Merck MRK | $58.97 B | 52,529.51% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $0.96 B | 757.54% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $2.00 B | 1,692.25% | 🇺🇸 USA |